Hong Kong IPO disclosure precedents · 84 companies, 86 items
Material acquisitions or disposals of companies completed during the track record, including consideration structures, goodwill and intangibles recognised, revenue/profit contribution, and consolidation timing effects on comparability.
In 2021, we acquired the unconsolidated regional operating entities in Indonesia and Thailand from relevant regional sponsors.
Business · p. 198
Revenue that we generated from unconsolidated regional operating entities contributed to 16% and 2%, respectively, of our revenue in 2020 and 2021.
Business · p. 199
Our average cost per parcel in Southeast Asia increased in 2021 due to our acquisition of certain unconsolidated regional operating entities in Indonesia and Thailand, which changed our cost structure in Southeast Asia.
From December 31, 2020 to December 31, 2021, our intangible assets increased significantly, mainly as a result of our acquisitions of Ideal Technology and Guangzhou Jianxin.
Financial Information · p. 351
Guangzhou Jianxin and its subsidiaries are primarily engaged in provision of intelligent platform and solutions in energy and power industry.
Financial Information · p. 351
Goodwill arising from the acquisition of Guangzhou Jianxin, Ideal Technology and EpicHust was monitored separately and assessed as separate CGUs for the purpose of impairment testing.
Upon completion of the acquisitions of the commercial properties property management business from the CNC Group by the Zhong An Group in April 2021, the property management business of both residential and non-residential properties has since then been operated by the Zhong An Group and the CNC Group has ceased to operate any property management business except for the hotel and cinema operation and management.
Business · p. 199
Our net current assets decreased by approximately RMB106.7 million to approximately RMB35.7 million as of December 31, 2021, mainly due to (i) decrease in cash and cash equivalents by RMB81.0 million as we settled the consideration payment to acquire the entire equity interest of (a) Zhejiang Runzhou, Yuyao Zhongli and Hangzhou Zhonghong and (b) Zhong An Management as part of the Reorganization;
In connection with the acquisition of Shangrao Adicon and Jiangxi Jince, the Group acquired 61% equity interests in Shangrao Adicon and Jiangxi Jince during 2021 at a total consideration of RMB45.7 million in cash, of which RMB27.7 million had been paid, RMB4.4 million remained in payables for investment and RMB18.1 million recognized as contingent consideration as of December 31, 2022.
Financial Information · p. 272
In addition, in connection with the acquisition of Henan Adicon, the Group acquired 51% equity interests in Henan Adicon during 2022 at a total consideration of RMB88.9 million in cash, of which RMB62.2 million had been paid and RMB26.7 million recognized as contingent consideration.
Financial Information · p. 272
Our net profit grew further by 112.5% from RMB322.3 million in 2021 to RMB684.9 million in 2022, primarily due to (i) continued business growth driven by laboratory expansion and significantly expanded test offering, (ii) increased economies of scale and higher operating efficiency, and (iii) an increase in fair value gains on derivative financial instruments and contingent consideration.
Our intangible assets increased from RMB62.7 million as of 31 December 2020 to RMB112.6 million as of 31 December 2021, primarily because we acquired (i) the right and related assets to operate a third party’s store on our Online Marketplace, and (ii) a subsidiary that held the medical institution practicing licence.
Financial Information · p. 266
Goodwill recorded on our balance sheet was related to our acquisition of Guangdong Dihao Pharmaceutical Co., Ltd. and Guangdong Dongjian Pharmaceutical Co., Ltd.
Financial Information · p. 266
Based on the result of the assessment, we determined that the recoverable amounts of all cashgenerating units are higher than the corresponding carrying amounts as of 31 December 2020, 2021 and 2022.